Healius Ltd (HLS)

Snapshot

HLS's Principal Activity is the provision of pathology, imaging and day hospitals and also facilities & support services to general practitioners, radiologists and other healthcare professionals.

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
13/09/2021	$0.0675	100%	$0.0964	Final	08/10/2021
25/03/2021	$0.065	100%	$0.0929	Interim	15/04/2021
26/03/2020	$0.026	100%	$0.0371	Interim	15/10/2020
29/08/2019	$0.034	100%	$0.0486	Final	27/09/2019
15/03/2019	$0.038	100%	$0.0543	Interim	26/03/2019
27/08/2018	$0.055	100%	$0.0786	Final	17/09/2018

Show All

See Upcoming Dividends for all ASX companies.

Key Data
DPS(TTM)	$0.1325
Gross DPS(TTM)	$0.1893
Dividend yield
Gross yield
Payout Ratio	66%
DRP	Yes
DRP Features	no discount

Directors & Management

Name	Title	Since	Bio
Ms Kathryn (Kate) Mary McKenzie	Non-Executive Director	Feb 2021	Ms Kathryn (Kate) Mary McKenzie Non-Executive Director Ms McKenzie was appointed as a Non-executive Director effective 25 February 2021. She was appointed as a member of the People & Governance Committee and as a member of the Risk Management Committee on the same date. She is a highly experienced Chief Executive Officer and Non-executive Director with experience in large change management. After starting her career in the public sector, she joined Telstra in 2004 as Group Managing Director Regulatory, Public Policy & Communications. In her 12 years at Telstra, she held a range of executive roles in strategy, marketing, products and wholesale. Prior to leaving Telstra, she was Chief Operating Officer, responsible for networks, IT, field services, property and NBN relations and delivery. In 2017 she was appointed Chief Executive Officer of Chorus, a New Zealand listed telecommunications company. She is passionate about innovation and technology, and co-founded muru-D, an incubator which has produced 44 graduating companies, with 41 still in operation; Gurrowa, a co-creation lab, and partnerships with universities, such as investment in Quantum Computing with the University of New South Wales
Ms Jennifer (Jenny) Mitchell Macdonald	Non-Executive Director	Nov 2020	Ms Jennifer (Jenny) Mitchell Macdonald Non-Executive Director Ms Macdonald was appointed as a Non-executive Director and Chair of the Audit Committee effective 3 November 2020. She has a strong background in financial and general management roles across a range of industry sectors including fast moving consumer goods, resources, travel and digital media. she commenced her career with KPMG, working in the London and Melbourne offices in a number of practice areas, including audit, she spent more than ten years with that firm. After gaining experience in the resources sector, she held executive roles in the travel and tourism industries and digital media at Flight Centre and REA Group. From 2014-2016 Jenny was the Chief Financial Officer and then Interim Chief Executive Officer of Helloworld, an ASX-listed multi-channel travel company.
Ms Alison Stephenson	Company Secretary	Aug 2019
Ms Sally Evans	Non-Executive Director	Aug 2018	Ms Sally Evans Non-Executive Director Ms Evans was appointed as a Non-executive Director in August 2018, also being appointed as a member of the Nomination and Remuneration Committee and the Risk Management Committee. On 19 August 2019, she was appointed as Chair of the newly renamed People & Governance Committee. Sally has over 30 years' experience in private, government and social enterprise sectors and has worked in Australia, New Zealand, the United Kingdom and Hong Kong with responsibilities across the broader Asia Pacific region. She has served as a Non-executive Director of Gateway Lifestyle Operations Limited.
Dr Malcolm Parmenter	Chief Executive Officer,Managing Director	Sep 2017	Dr Malcolm Parmenter Chief Executive Officer,Managing Director Dr Parmenter joined Healius as Managing Director and Chief Executive Officer (CEO) in September 2017. He has a wealth of knowledge and practical experience in the operation of frontline care, with over nine years' tenure as CEO of Independent Practitioner Network Limited (IPN), both as a listed company and under the ownership of Sonic Healthcare Limited, and subsequently two years as CEO of Sonic Clinical Services. He has a strong understanding of healthcare delivery, both in Australia and abroad, and has spent more than 20 years as a General Practitioner.
Mr Gordon Richard Davis	Non-Executive Director	Aug 2015	Mr Gordon Richard Davis Non-Executive Director Mr Davis was appointed as a member of the Risk Management Committee and as Chair of the Risk Management Committee on 19 August 2019, at which time he ceased as Audit Committee Chair but remained a member of that committee. Prior to becoming a Non-executive Director, Gordon was Managing Director of AWB Limited between 2006 and 2010. He has also served in a senior capacity on various industry associations.
Mr Charles Tilley	Company Secretary	Feb 2015
Mr Robert Hubbard	Non-Executive Director,Non-Executive Chairman	Dec 2014	Mr Robert Hubbard Non-Executive Director,Non-Executive Chairman Mr Hubbard was a member of the Risk Management Committee up to that date. Rob Birmingham. He previously held partnership positions in the accounting, corporate finance, assurance and audit divisions of PricewaterhouseCoopers and acted as external auditor for some of Australia's largest ASX-listed companies.
Dr Paul Francis Jones	Non-Executive Director	Nov 2010	Dr Paul Francis Jones Non-Executive Director Dr Jones was appointed as a Non-executive Director in November 2010. During FY 2021, he was a member of the Audit Committee (from 25 February 2021), the People & Governance Committee and the Risk Management Committee (the latter until 25 February 2021). He has over 35 years' experience in a broad range of general medical practice, including 15 years' experience in Healius Group medical centres. He originally trained at the Repatriation and General Hospital, Concord NSW and subsequently at Calvary Public Hospital, Bruce ACT. He has been a Director and Federal Councillor of the Australian Medical Association (AMA), a past President of AMA ACT and a member of the Federal AMA Council of General Practice. He was formerly a general practitioner adviser to Calvary Public Hospital and held roles as GPVMO and Director, Medical Education Program. He is a former Chair of ACT GP Workforce Working Group and was a member of the ACT Health Minister's GP Task Force in 2009
Dean Lewsam	Chief Executive Imaging	N/A
John McKechnie	Chief Executive Pathology	N/A
Maxine Jaquet	Chief Financial Officer & Chief Operating Officer (CFO & COO)	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
06/09/21	Malcolm Parmenter	Expiry	80,498	$5.00	$402,490	As advised by the company
06/09/21	Malcolm Parmenter	Issued	724,482	$5.00	$3,622,410	Conversion of securities
06/09/21	Malcolm Parmenter	Exercise	724,482	$5.00	$3,622,410	Conversion of securities
01/09/21	Jennifer (Jenny) Macdonald	Buy	+10,000	$4.99	$49,900	On-market trade
01/09/21	Jennifer (Jenny) Macdonald	Buy	+10,000	$4.98	$49,800	On-market trade
31/08/21	Sally Evans	Buy	+7,173	$3.485	$24,997	Conversion of securities
31/08/21	Sally Evans	Exercise	7,173	$3.485	$24,997	Conversion of securities
31/08/21	Robert Hubbard	Buy	+14,346	$3.482	$49,954	Conversion of securities
31/08/21	Robert Hubbard	Exercise	14,346	$3.482	$49,954	Conversion of securities
31/08/21	Paul Jones	Buy	+5,738	$3.485	$19,999	Conversion of securities
31/08/21	Paul Jones	Exercise	5,738	$3.485	$19,999	Conversion of securities
26/02/21	Kathryn (Kate) McKenzie	Buy	+2,500	$4.07	$10,175	On-market trade
25/02/21	Robert Hubbard	Buy	+7,172	$3.483	$24,977	Conversion of securities
25/02/21	Robert Hubbard	Exercise	7,172	$3.483	$24,977	Conversion of securities
25/02/21	Sally Evans	Buy	+3,586	$3.485	$12,498	Conversion of securities
25/02/21	Sally Evans	Exercise	3,586	$3.485	$12,498	Conversion of securities
10/12/20	Paul Jones	Buy	+2,869	$3.485	$9,999	Conversion of securities
10/12/20	Paul Jones	Exercise	2,869	$3.485	$9,999	Conversion of securities
10/12/20	Sally Evans	Issued	10,759	$3.485	$37,500	Directors' share plan
10/12/20	Robert Hubbard	Issued	21,518	$3.485	$75,000	Directors' share plan
10/12/20	Paul Jones	Issued	8,607	$3.486	$30,000	Directors' share plan
10/11/20	Jennifer (Jenny) Macdonald	Buy	+15,000	$3.51	$52,650	On-market trade
14/08/20	Malcolm Parmenter	Expiry	475,180	$3.18	$1,511,072	As advised by the company
01/07/20	Malcolm Parmenter	Exercise	26,537	$3.10	$82,264	Conversion of securities
01/07/20	Malcolm Parmenter	Issued	26,537	$3.10	$82,264	Conversion of securities
03/03/20	Malcolm Parmenter	Issued	11,081,391	$3.01	$33,354,987	Issue of options
25/11/19	Errol Katz	Transfer	25,000	$3.04	$76,000	Off-market transfer
25/11/19	Errol Katz	Transfer	25,000	$3.04	$76,000	Off-market transfer
13/09/19	Sally Evans	Buy	+15,000	$3.26	$48,900	On-market trade
19/08/19	Robert Hubbard	Buy	+25,000	$3.086	$77,150	On-market trade
29/01/19	Malcolm Parmenter	Issued	804,980	$2.90	$2,334,442	Issue of securities
21/12/18	Errol Katz	Buy	+13,080	$2.25	$29,430	On-market trade
27/11/18	Arlene Tansey	Buy	+4,000	$2.52	$10,080	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Malcolm Parmenter	06/09/2021	776,480	59,597	11,081,391	N/A
Jennifer (Jenny) Macdonald	01/09/2021	35,000	N/A	N/A	N/A
Sally Evans	31/08/2021	10,759	15,000	N/A	N/A
Paul Jones	31/08/2021	8,607	40,588	0	N/A
Robert Hubbard	31/08/2021	21,518	76,951	N/A	N/A
Kathryn (Kate) McKenzie	30/06/2021	N/A	2,500	N/A	N/A
Gordon Davis	30/06/2021	N/A	55,759	N/A	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
HSBC Custody Nominees (Australia) Limited	175,386,356	29.29%
Citicorp Nominees Pty Limited	112,031,380	18.71%
J P Morgan Nominees Australia Pty Limited	89,264,817	14.91%
National Nominees Pty Ltd	71,170,798	11.88%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C>	20,574,535	3.44%
Argo Investments Limited	16,320,664	2.73%
BNP Paribas Noms Pty Ltd <DRP>	11,463,079	1.91%
HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C>	10,184,406	1.70%
Cs Third Nominees Pty Limited <HSBC Cust Nom Au Ltd 13 A/C>	6,229,569	1.04%
Citicorp Nominees Pty Ltd <Colonial First State Inv A/C>	4,285,700	0.72%
RinRim Pty Ltd	2,392,047	0.40%
BNP Paribas Nominees Pty Ltd Six Sis Ltd <DRP A/C>	1,761,260	0.29%
UBS Nominees Pty Ltd	1,057,466	0.18%
HSBC Custody Nominees (Australia) Limited <GSCO Customer A/C>	997,257	0.17%
AMP Life Limited	811,628	0.14%
Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <Drp A/C>	799,450	0.13%
Nulis Nominees (Australia) Limited <Navigator Mast Plan Sett A/C>	784,767	0.13%
Joromada Pty Ltd	710,000	0.12%
Navigator Australia Ltd <MLC Investment Sett A/C>	708,490	0.12%
Merrill Lynch (Australia) Nominees Pty Limited	695,511	0.12%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$3.05	30 June
2019	$3.02	28 June
2016	$0.005	28 June
2015	$0.003	30 June
2014	$0.006	30 June

HLS Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.